Literature DB >> 8719816

Different effects of fibrates on the microsomal fatty acid chain elongation and the acyl composition of phospholipids in guinea-pigs.

M Vázquez1, M Alegret, M López, C Rodríguez, T Adzet, M Merlos, J C Laguna.   

Abstract

1. The effects in vitro and in vivo of three fibric acid derivatives, clofibrate (CFB), bezafibrate (BFB) and gemfibrozil (GFB) on some enzyme activities related to fatty acid biosynthesis, namely palmitoyl-CoA synthetase and hydrolases (microsomal and cytosolic), NADH and NADPH cytochrome c reductases and acyl-CoA elongases were investigated in guinea-pigs. 2. The three fibrates inhibited acyl-CoA elongation in vitro, irrespective of the substrate of elongation used (saturated, monounsaturated, polyunsaturated) and with an order of potency GFB > BFB > CFB. In the case of GFB, inhibition occurred at concentrations that can be reached in vivo. 3. Microsomal palmitoyl-CoA hydrolase and synthetase were also inhibited in vitro (GFB > or = BFB > CFB), whereas NADH cytochrome c reductase activity was increased by GFB. Nevertheless, the magnitude of changes were lower than those observed in elongation activities. 4. Treatment with fibrates did not produce peroxisomal proliferation in guinea-pigs, as measured by peroxisomal beta-oxidation activity and liver weight/body weight ratio. Nevertheless, fibrates provoked a reduction in plasma cholesterol and triglycerides, at least in GFB- and BFB-treated animals. 5. Fatty acid elongation was significantly modified by GFB treatment in vivo. The remaining enzyme activities studied were only slightly changed by fibrate treatment. 6. Treatment with BFB and to a lesser extent with CFB, increased the relative proportion of MUFA (palmitoleic and oleic acids) in microsomal phospholipids, whereas PUFA (mainly linoleic acid) decreased. GFB behaved differently, increasing palmitic and linoleic acids and decreasing stearic and oleic acids. The latter changes are attributable to an inhibition of elongation activity by GFB. 7. The changes observed after fibrate treatment in both rats and guinea-pigs, as they are not directly related to peroxisome proliferation, could be more reliably extrapolated to man than those observed only in rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719816      PMCID: PMC1909193          DOI: 10.1111/j.1476-5381.1995.tb15144.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Differential inhibition of long-chain acyl-CoA hydrolases by hypolipidemic drugs in vitro.

Authors:  R M Sánchez; M Alegret; T Adzet; M Merlos; J C Laguna
Journal:  Biochem Pharmacol       Date:  1992-02-04       Impact factor: 5.858

Review 2.  Structure and functional properties of lipoprotein lipase.

Authors:  C S Wang; J Hartsuck; W J McConathy
Journal:  Biochim Biophys Acta       Date:  1992-01-03

Review 3.  Mode of action of fibrates.

Authors:  A L Catapano
Journal:  Pharmacol Res       Date:  1992-12       Impact factor: 7.658

4.  Differential effects of fibrates on the acyl composition of microsomal phospholipids in rats.

Authors:  M Vázquez; S Muñoz; M Alegret; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

5.  Cytosolic lipogenic enzymes: effect of fibric acid derivatives in vitro.

Authors:  R M Sánchez; M Vázquez; M Alegret; M Viñals; T Adzet; M Merlos; J C Laguna
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

6.  Fibrates modify rat hepatic fatty acid chain elongation and desaturation in vitro.

Authors:  R M Sánchez; M Viñals; M Alegret; M Vázquez; T Adzet; M Merlos; J C Laguna
Journal:  Biochem Pharmacol       Date:  1993-11-17       Impact factor: 5.858

Review 7.  Tolerability of fibric acids. Comparative data and biochemical bases.

Authors:  C R Sirtori; L Calabresi; J P Werba; G Franceschini
Journal:  Pharmacol Res       Date:  1992 Oct-Nov       Impact factor: 7.658

8.  Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.

Authors:  M Alegret; R Ferrando; M Vázquez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

9.  Selective modification of rat hepatic microsomal fatty acid chain elongation and desaturation by fibrates: relationship with peroxisome proliferation.

Authors:  M Alegret; E Cerqueda; R Ferrando; M Vázquez; R M Sánchez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Effect of gemfibrozil on fatty acids in lipid fractions of plasma from patients with hypertriglyceridemia.

Authors:  M Tavella; C N Corder; W McConathy
Journal:  J Clin Pharmacol       Date:  1993-01       Impact factor: 3.126

View more
  2 in total

Review 1.  How lipids may affect risk for suicidal behavior.

Authors:  Federico M Daray; J John Mann; M Elizabeth Sublette
Journal:  J Psychiatr Res       Date:  2018-06-12       Impact factor: 4.791

2.  Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation.

Authors:  Marc Engelen; Martin J A Schackmann; Rob Ofman; Robert-Jan Sanders; Inge M E Dijkstra; Sander M Houten; Stéphane Fourcade; Aurora Pujol; Bwee Tien Poll-The; Ronald J A Wanders; Stephan Kemp
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.